Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: Envista Holdings Corporation, 3 years.
Envista Holdings Corporation
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Envista Holdings Corporation May 19, 202698.8%
-
Envista Holdings Corporation June 10, 202598.6%
-
Envista Holdings Corporation May 21, 202497.5%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 19, 2026 | Envista Holdings Corporation | Grant or award | +9,330 | — | — |
| Jun 10, 2025 | Envista Holdings Corporation | Grant or award | +10,450 | — | — |
| Dec 2, 2024 | Boston Scientific Corporation | Option exercise | +3,066 | $17.26 | $52,919 |
| Dec 2, 2024 | Boston Scientific Corporation | Option exercise | +1,197 | $24.55 | $29,386 |
| Dec 2, 2024 | Boston Scientific Corporation | Open-market sale | −6,983 | $90.78 | $633,917 |
| Nov 1, 2024 | Boston Scientific Corporation | Option exercise | +3,066 | $17.26 | $52,919 |
| Nov 1, 2024 | Boston Scientific Corporation | Option exercise | +1,197 | $24.55 | $29,386 |
| Nov 1, 2024 | Boston Scientific Corporation | Open-market sale | −6,983 | $84.33 | $588,876 |
| Oct 1, 2024 | Boston Scientific Corporation | Option exercise | +3,066 | $17.26 | $52,919 |
| Oct 1, 2024 | Boston Scientific Corporation | Option exercise | +1,197 | $24.55 | $29,386 |
| Oct 1, 2024 | Boston Scientific Corporation | Open-market sale | −6,983 | $83.86 | $585,594 |
| Sep 3, 2024 | Boston Scientific Corporation | Option exercise | +3,066 | $17.26 | $52,919 |
| Sep 3, 2024 | Boston Scientific Corporation | Option exercise | +1,197 | $24.55 | $29,386 |
| Sep 3, 2024 | Boston Scientific Corporation | Open-market sale | −6,983 | $81.70 | $570,511 |
| Aug 1, 2024 | Boston Scientific Corporation | Option exercise | +3,066 | $17.26 | $52,919 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.